Enzo Biochem (ENZ) Posts Narrower than Expected Q3 Loss
Tweet Send to a FriendGet Alerts ENZ Hot Sheet
Price: $2.25 -1.32%
EPS Growth %: -250.0%
Financial Fact:
Cost of product revenues: 4.14M
Today's EPS Names:
ZLC, TOL, TGT, More
EPS Growth %: -250.0%
Financial Fact:
Cost of product revenues: 4.14M
Today's EPS Names:
ZLC, TOL, TGT, More
Trade ENZ Now!
Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 loss of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $25.8 million versus the consensus estimate of $24.77 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Ryanair Holdings plc (RYAAY) Reports Improved Q1 EPS of EUR0.39
- UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
